These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1888 related articles for article (PubMed ID: 34620126)

  • 1. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
    Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J
    BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
    Zhu X; Du J; Gu Z
    Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
    Han L; Cheng J; Li A
    Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
    [No Abstract]   [Full Text] [Related]  

  • 4. LncRNA DANCR regulates the growth and metastasis of oral squamous cell carcinoma cells via altering miR-216a-5p expression.
    Qu XH; Shi YL; Ma Y; Bao WW; Yang L; Li JC; Zhang F
    Hum Cell; 2020 Oct; 33(4):1281-1293. PubMed ID: 32860589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect and mechanism of circular RNA BICD2 on the biological behavior of oral squamous cell carcinoma cells].
    Zhang YJ; Zhu QQ; Zhou HX; Wang HY; Zhou H
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Nov; 56(11):1098-1108. PubMed ID: 34763405
    [No Abstract]   [Full Text] [Related]  

  • 6. The novel circ_0004674/miR-139-5p/ZBTB2 regulatory cascade inhibits the development of oral squamous cell carcinoma.
    Qi C; Zhang L; Wang W
    Head Neck; 2024 Jul; 46(7):1671-1682. PubMed ID: 38665011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. circ_0005379 inhibits the progression of oral squamous cell carcinoma by regulating the miR-17-5p/acyl-CoA oxidase 1 axis.
    Zhou HX; Wang LY; Chen S; Wang DD; Fang Z
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Aug; 39(4):425-433. PubMed ID: 34409798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. circBICD2 targets miR-149-5p/IGF2BP1 axis to regulate oral squamous cell carcinoma progression.
    Qiu L; Zheng L; Gan C; Deng W; Sun Y; Wang T
    J Oral Pathol Med; 2021 Aug; 50(7):668-680. PubMed ID: 33382158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circ-KIAA0907 inhibits the progression of oral squamous cell carcinoma by regulating the miR-96-5p/UNC13C axis.
    Dong W; Zhao L; Zhang S; Zhang S; Si H
    World J Surg Oncol; 2021 Mar; 19(1):75. PubMed ID: 33715625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis.
    Wang T; Mao P; Feng Y; Cui B; Zhang B; Chen C; Xu M; Gao K
    Cell Cycle; 2021 Jun; 20(12):1181-1194. PubMed ID: 34024251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0005320 promotes oral squamous cell carcinoma tumorigenesis by sponging microRNA-486-3p and microRNA-637.
    Zheng X; Du F; Gong X; Xu P
    Bioengineered; 2022 Jan; 13(1):440-454. PubMed ID: 34967281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway.
    Peng QS; Cheng YN; Zhang WB; Fan H; Mao QH; Xu P
    Cell Death Dis; 2020 Feb; 11(2):112. PubMed ID: 32041942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ_0006988 promotes the proliferation, metastasis and angiogenesis of non-small cell lung cancer cells by modulating miR-491-5p/MAP3K3 axis.
    Yang C; Shi J; Wang J; Hao D; An J; Jiang J
    Cell Cycle; 2021 Jul; 20(13):1334-1346. PubMed ID: 34189997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis.
    Wang L; Hou S; Li J; Tian T; Hu R; Yu N
    Bioengineered; 2022 Jan; 13(1):1209-1223. PubMed ID: 34982022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA circ_0007142 regulates cell proliferation, apoptosis, migration and invasion via miR-455-5p/SGK1 axis in colorectal cancer.
    Wen T; Wu H; Zhang L; Li K; Xiao X; Zhang L; Zhang Y
    Anticancer Drugs; 2021 Jan; 32(1):22-33. PubMed ID: 32889894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_0001971 regulates oral squamous cell carcinoma progression and chemosensitivity by targeting miR-194/miR-204 in vitro and in vivo.
    Tan X; Zhou C; Liang Y; Lai YF; Liang Y
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2470-2481. PubMed ID: 32196598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0091579 Serves as a Tumor-Promoting Factor in Hepatocellular Carcinoma Through miR-1225-5p/PLCB1 Axis.
    Zhang D; Zhang Y; Zhang X; Zhai H; Sun X; Li Y
    Dig Dis Sci; 2022 Feb; 67(2):585-597. PubMed ID: 33559088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA circ-FAM158A promotes retinoblastoma progression by regulating miR-138-5p/SLC7A5 axis.
    Zheng T; Chen W; Wang X; Cai W; Wu F; Lin C
    Exp Eye Res; 2021 Oct; 211():108650. PubMed ID: 34102206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_LPAR3 promotes the progression of oral squamous cell carcinoma (OSCC).
    Li L; Yin Y; Nan F; Ma Z
    Biochem Biophys Res Commun; 2022 Jan; 589():215-222. PubMed ID: 34922206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 95.